| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/24/2007 | US7208487 Inhibitors of KSP, a mitotic kinesin for treating proliferative diseases such as cancer; 3-Benzyl-7-chloro-2-[2-methyl-1-(7-oxo-[1,4]diazepan-1-yl)-propyl]-3H-quinazolin-4-one for example |
| 04/24/2007 | US7208486 Vascular conditions such as atherosclerosis, hypercholesterolemia, diabetes, obesity, stroke, demyelination; lowering plasma levels of sterols and/or stanols |
| 04/24/2007 | US7208485 Crystalline forms of halobetasol propionate |
| 04/24/2007 | US7208484 Osteoporosis; skin disorders; condensation bicyclic ketone with allylic phosphine |
| 04/24/2007 | US7208482 9-aminoacyl tetracycline compounds and methods of use thereof |
| 04/24/2007 | US7208481 Monitoring the protein concentration in plasma or tissues; treating atherosclerosis, Alzheimer's disease, macular degeneration, retinitis pigmentosa, stroke, degenerative neuropathy, multiple sclerosis, xanthoma, xanthelasma, cardiovascular disorder; tetramethyl N-(2-pyridyl)aminomethylenediphosphonate |
| 04/24/2007 | US7208480 Polysaccharide based gel |
| 04/24/2007 | US7208479 Peritoneal dialysis solution containing modified icodextrins |
| 04/24/2007 | US7208478 Immunostimulatory polynucleotide/immunomodulatory molecule conjugates |
| 04/24/2007 | US7208477 Treatments for benign tumors, cancers, neoplasias, and/or other inflammatory disorders or diseases |
| 04/24/2007 | US7208467 Administering a compound altering transfer of cholesterol or cholesteryl ester from high density lipoprotein or other lipoproteins via SR-BI to liver or steroidogenic tissues or compounds blocking oxidative modification of LDL |
| 04/24/2007 | US7208401 Method for forming a thin film |
| 04/24/2007 | US7208300 Enzymatic polypetide for use in the treatment of aneurysms and artheroslerosis |
| 04/24/2007 | US7208297 Nucleotide sequence encoding a polypeptide derived from fungus Thraustochytrium aureum; expression of vector results in production of polyunsaturated fatty acid (omega 6-docosapentaenoic acid and docosahexaenoic acid); use in pharmaceutical compositions, animal feeds and cosmetics |
| 04/24/2007 | US7208283 Contacting with Ewing sarcoma protein and nuclear receptor; determining binding and changes in ligand-induced activity; use in diagnosis and treatment |
| 04/24/2007 | US7208267 Compositions and methods relating to breast specific genes and proteins |
| 04/24/2007 | US7208182 Cyclooxygenase-2 inhibitory withanolide compositions and method |
| 04/24/2007 | US7208180 Oral administration of a preparation having a) long chain polyunsaturated fatty acids, and b) specified phospholipids, and c) compounds that factor in methionine metabolism, such as folate, B vitamins, magnesium and zinc |
| 04/24/2007 | US7208178 For facilitating the delivery of active agents, such as insulin, to a target |
| 04/24/2007 | US7208176 Respiratory system disorders; viricides; mixture of antihistamine and enzyme inhibitor |
| 04/24/2007 | US7208162 Combination therapy of respiratory diseases using antibodies and anti-inflammatory agents |
| 04/24/2007 | US7208153 Method for the improvement of neuronal regeneration |
| 04/24/2007 | US7208149 IL-16 antagonist peptides and DNA encoding the peptides |
| 04/24/2007 | US7208145 Polymeric reagents comprising a ketone or a related functional group |
| 04/24/2007 | US7208141 Inhalable aztreonam aerosol for treatment and prevention of pulmonary bacterial infections |
| 04/24/2007 | CA2410852C 1-amino-alkylcyclohexanes as 5-ht3 and neuronal nicotinic receptor antagonists |
| 04/24/2007 | CA2407763C Para-amine substituted phenylamide glucokinase activators |
| 04/24/2007 | CA2403902C Malonamic acids and derivatives thereof as thyroid receptor ligands |
| 04/24/2007 | CA2378671C 6-o-carbamate ketolide derivatives |
| 04/24/2007 | CA2374269C Stimulating transport of glucose into animal tissue by the administration of pinitol |
| 04/24/2007 | CA2374091C The combined use of triglycerides containing medium chain fatty acids and exogenous lipolytic enzymes as feed supplements |
| 04/24/2007 | CA2353528C Use of ibandronate for promoting osseointegration of endoprostheses |
| 04/24/2007 | CA2340343C Enantioselective synthesis |
| 04/24/2007 | CA2332931C The treatment of renal colic with gaba analogs |
| 04/24/2007 | CA2322471C S-substituted 11.beta.-benzaldoxime-estra-4,9-diene-carbonic acid thiolesters, method for the production thereof and pharmaceutical preparations containing these compounds |
| 04/24/2007 | CA2309688C Penetration enhancing and irritation reducing systems |
| 04/24/2007 | CA2307820C Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them |
| 04/24/2007 | CA2303763C Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists |
| 04/24/2007 | CA2301135C Rapidly disintegrating methylcellulose tablets |
| 04/24/2007 | CA2289574C 8-azabicyclo(3,2,1)oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ach receptors |
| 04/24/2007 | CA2289472C Excitatory amino acid receptor modulators |
| 04/24/2007 | CA2288722C Method of treating isolated systolic hypertension |
| 04/24/2007 | CA2281545C N-heterocyclic derivatives as nos inhibitors |
| 04/24/2007 | CA2279648C Haemostatic aerosol composition |
| 04/24/2007 | CA2254848C Methods for sterilizing male mammals |
| 04/24/2007 | CA2243708C Use of lactoperoxidase, a peroxide donor and thiocyanate for the manufacture of a medicament for treating helicobacter pylori infection |
| 04/24/2007 | CA2236482C Expression of cyclin g1 in tumors |
| 04/24/2007 | CA2234610C New amino acid derivatives, processes for preparing them and pharmaceutical compositions containing these compounds |
| 04/24/2007 | CA2203155C Water-soluble epipodophyllotoxin derivatives, preparation method therefor, and use thereof as a drug and for treating cancer |
| 04/24/2007 | CA2202485C Synergistic antimicrobial composition comprising a carboxylic acid and a c3-c10-diol |
| 04/24/2007 | CA2197793C New multimerizing agents |
| 04/24/2007 | CA2184345C Coordinate in vivo gene expression |
| 04/24/2007 | CA2182771C 11-(substituted phenyl)-estra-4,9-diene derivatives |
| 04/24/2007 | CA2179584C Pharmaceutical composition containing insulin sensitivity enhancer in combination with another antidiabetic |
| 04/24/2007 | CA2171934C Endothelin receptor antagonists |
| 04/24/2007 | CA2170454C Process for the preparation of ivermectin |
| 04/24/2007 | CA2167171C A method of protecting against neuron loss |
| 04/24/2007 | CA2166811C Tricyclic inhibitors of the gpiibiiia receptor |
| 04/24/2007 | CA2159776C Imidobisphosphoric acids, process for their preparation, and use thereof |
| 04/24/2007 | CA2154485C Pharmaceutical composition containing 5-morpholinomethyl-3-(4-chlorobenzylideneamine)-2-oxazolidinone and its use for the treatment of cns disorders |
| 04/24/2007 | CA2144312C Unsaturated aliphatic dicarboxylic acids |
| 04/24/2007 | CA2138451C Sugar-coated pharmaceutical dosage unit |
| 04/24/2007 | CA2131644C Quinoline compounds |
| 04/24/2007 | CA2112703C Method for the inhibition of aldh-i useful in the treatment of alcohol dependence or alcohol abuse |
| 04/24/2007 | CA2075173C Compounds and methods for inhibition of hiv and related viruses |
| 04/24/2007 | CA2073855C Glycoalkaloids for controlling cellular autophagy |
| 04/19/2007 | WO2007044989A2 Modulators of nod1 signaling |
| 04/19/2007 | WO2007044982A2 Methods for the preservation of platelet efficacy during storage |
| 04/19/2007 | WO2007044973A2 Acyclic n-halamines in antibacterial materials |
| 04/19/2007 | WO2007044933A1 Hepatitis c virus inhibitors |
| 04/19/2007 | WO2007044927A2 6, 11-bridged tricyclic macrolides |
| 04/19/2007 | WO2007044910A1 Compositions for the treatment and prevention of heart disease and methods of using same |
| 04/19/2007 | WO2007044906A2 Compositions and methods for enhanced gastrointestinal stability of oligopeptides and polypeptides |
| 04/19/2007 | WO2007044902A2 Use of benzyl nicotinate for pain relief |
| 04/19/2007 | WO2007044885A2 Piperidine derivatives and methods of use |
| 04/19/2007 | WO2007044813A1 PYRIDOPYRIMIDINONE INHIBITORS OF PI3Kα |
| 04/19/2007 | WO2007044804A2 Piperidine derivatives and methods of use |
| 04/19/2007 | WO2007044796A2 Pyridazinone compounds as calcilytics |
| 04/19/2007 | WO2007044779A1 Kinase inhibitors |
| 04/19/2007 | WO2007044752A2 Treating skin disorders |
| 04/19/2007 | WO2007044726A2 Methods for reducing platelet activation and for the treatment of thrombotic events |
| 04/19/2007 | WO2007044713A1 Solid dispersions of opioid antagonists |
| 04/19/2007 | WO2007044700A2 Protectant combinations for reducing toxicities |
| 04/19/2007 | WO2007044698A1 PYRIDOPYRIMIDINONE INHIBITORS OF PI3Kα |
| 04/19/2007 | WO2007044693A2 Multi-functional ionic liquid compositions |
| 04/19/2007 | WO2007044682A2 Method for treating chronic pain |
| 04/19/2007 | WO2007044679A2 Treating metabolic syndrome with 2-deoxy-d-glucose |
| 04/19/2007 | WO2007044664A1 Compositions and methods for reducing food intake and controlling weight |
| 04/19/2007 | WO2007044659A2 Nanosized carotenoid cyclodextrin complexes |
| 04/19/2007 | WO2007044641A2 Glutathione peroxidase mimetics and uses thereof |
| 04/19/2007 | WO2007044639A2 Novel delivery of immune response modifiers for removal of chronic tattoos |
| 04/19/2007 | WO2007044580A1 Methods for reducing weight |
| 04/19/2007 | WO2007044574A2 Pharmaceutical compositions, methods of preparation thereof, and methods of treatment |
| 04/19/2007 | WO2007044565A2 Composition and synthesis of new reagents for inhibition of hiv replication |
| 04/19/2007 | WO2007044560A2 Modulators of atp-binding cassette transporters |
| 04/19/2007 | WO2007044559A1 System and method for the prevention of bacterial and fungal infections including urinary tract infections (uti) using n-halogenated amino acids |
| 04/19/2007 | WO2007044547A1 Methods for achieving and maintaining weight loss |
| 04/19/2007 | WO2007044491A1 N-substituted pyridinone or pyrimidinone compounds useful as soluble epoxide hydrolase inhibitors |
| 04/19/2007 | WO2007044488A1 Enteric soft capsule comprising valproic acid |
| 04/19/2007 | WO2007044475A1 Process for the synthesis of compounds for selectin inhibition |